FIELD: medicine.
SUBSTANCE: invention relates to a compound of the formula (I), to its pharmaceutically acceptable salt or solvate, and to their solid forms, in which R1 is methyl or ethyl; R2 is selected from methyl, ethyl, methoxy and ethoxy; R3 is selected from hydrogen, chlorine, fluorine, bromine and methyl; R4 is selected from methyl, ethyl and -CH2OCH3; each of R5 and R6 is individually methyl or hydrogen; and R7 is selected from methyl, ethyl, -(СН2)2ОН and -(СН2)2OCH3. The invention also relates to a pharmaceutical composition for the treatment of JAK-related disorder based on the specified compounds.
EFFECT: new compounds and a pharmaceutical composition based on them are obtained, which can be used in medicine for the treatment of cancer.
28 cl, 32 dwg, 32 tbl, 73 ex
Title | Year | Author | Number |
---|---|---|---|
SELECTIVE KINASE JAK1 INHIBITOR | 2020 |
|
RU2818002C2 |
NEW BICYCLIC DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2760554C1 |
NOVEL THIENO-PYRIMIDINE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2014 |
|
RU2605403C2 |
NOVEL AMINO ACID DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2747673C2 |
NOVEL HYDROXY ACID DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2745430C1 |
BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2012 |
|
RU2662827C2 |
PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE PREVENTION OR TREATMENT OF CANCER | 2019 |
|
RU2807277C2 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
NOVEL HYDROXY-ESTER DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2734418C2 |
SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
Authors
Dates
2021-11-24—Published
2016-09-22—Filed